These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32646765)

  • 1. Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort.
    Ruiz-Quintero M; Redón J; Téllez-Plaza M; Cebrián-Cuenca AM; Navarro-Pérez J; Menéndez E; Perez-Navarro A; Fernández-Giménez A; López-Pineda A; Quesada JA; Pallares-Carratalá V; Gil-Guillen VF; Martin-Moreno JM; Bleda-Cano J; Carrascosa S; Carratalá-Munuera C
    Prim Care Diabetes; 2021 Feb; 15(1):88-94. PubMed ID: 32646765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort: the Estudio Cardiovascular Valencia-risk study.
    Tellez-Plaza M; Orozco-Beltran D; Gil-Guillen V; Pita-Fernandez S; Navarro-Pérez J; Pallares V; Valls F; Fernandez A; Perez-Navarro AM; Sanchis C; Dominguez-Lucas A; Martin-Moreno JM; Redon J;
    J Hypertens; 2016 Nov; 34(11):2266-73. PubMed ID: 27584973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
    Wanner C; Lachin JM; Inzucchi SE; Fitchett D; Mattheus M; George J; Woerle HJ; Broedl UC; von Eynatten M; Zinman B;
    Circulation; 2018 Jan; 137(2):119-129. PubMed ID: 28904068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
    Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC
    Am J Kidney Dis; 2021 Jan; 77(1):23-34.e1. PubMed ID: 32971190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalizations among adults with chronic kidney disease in the United States: A cohort study.
    Schrauben SJ; Chen HY; Lin E; Jepson C; Yang W; Scialla JJ; Fischer MJ; Lash JP; Fink JC; Hamm LL; Kanthety R; Rahman M; Feldman HI; Anderson AH;
    PLoS Med; 2020 Dec; 17(12):e1003470. PubMed ID: 33306688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region.
    Gil-Terrón N; Cerain-Herrero MJ; Subirana I; Rodríguez-Latre LM; Cunillera-Puértolas O; Mestre-Ferrer J; Grau M; Dégano IR; Elosua R; Marrugat J; Ramos R; Baena-Díez JM; Salvador-González B
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):212-218. PubMed ID: 30709697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors.
    Cea Soriano L; Johansson S; Stefansson B; Rodríguez LA
    Cardiovasc Diabetol; 2015 Apr; 14():38. PubMed ID: 25909295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury.
    James MT; Grams ME; Woodward M; Elley CR; Green JA; Wheeler DC; de Jong P; Gansevoort RT; Levey AS; Warnock DG; Sarnak MJ;
    Am J Kidney Dis; 2015 Oct; 66(4):602-12. PubMed ID: 25975964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study.
    Navarro-Pérez J; Orozco-Beltran D; Gil-Guillen V; Pallares V; Valls F; Fernandez A; Perez-Navarro AM; Sanchis C; Dominguez-Lucas A; Martin-Moreno JM; Redon J; Tellez-Plaza M;
    BMC Cardiovasc Disord; 2018 Sep; 18(1):180. PubMed ID: 30176799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between reduced renal function and cardiovascular mortality in patients hospitalized with infection: A multi-center cohort study.
    Su G; Xu Y; Xu X; Xu H; Lu L; Marrone G; Lindholm B; Wen Z; Liu X; Johnson DW; Carrero JJ; Stålsby Lundborg C
    Eur J Intern Med; 2018 Nov; 57():32-38. PubMed ID: 29958748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Kidney Function, Albuminuria, and Risks for All-cause and Cardiovascular Mortality in China: A Population-based Cohort Study.
    Wang J; Wang F; Liu S; Zhou M; Zhang L; Zhao M
    BMC Nephrol; 2017 Jun; 18(1):188. PubMed ID: 28592243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
    Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Influenza Vaccination Among Older Adults Across Kidney Function: Pooled Analysis of 2005-2006 Through 2014-2015 Influenza Seasons.
    Ishigami J; Sang Y; Grams ME; Coresh J; Chang A; Matsushita K
    Am J Kidney Dis; 2020 Jun; 75(6):887-896. PubMed ID: 31813664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
    BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents.
    Okuda Y; Soohoo M; Tang Y; Obi Y; Laster M; Rhee CM; Streja E; Kalantar-Zadeh K
    Am J Kidney Dis; 2019 Jun; 73(6):797-805. PubMed ID: 30833086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study.
    Redon J; Tellez-Plaza M; Orozco-Beltran D; Gil-Guillen V; Pita Fernandez S; Navarro-Pérez J; Pallares V; Valls F; Fernandez A; Perez-Navarro AM; Sanchis C; Dominguez-Lucas A; Sanz G; Martin-Moreno JM;
    J Hypertens; 2016 Jun; 34(6):1075-83. PubMed ID: 27074896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Lo KB; Gul F; Ram P; Kluger AY; Tecson KM; McCullough PA; Rangaswami J
    Cardiorenal Med; 2020; 10(1):1-10. PubMed ID: 31743918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study.
    Calvo-Hueros JI; Martín-Hidalgo-Barquero MV; Morales-Gabardino JA; Buitrago F
    Prim Care Diabetes; 2021 Apr; 15(2):391-396. PubMed ID: 33323354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.